CLChristina M. Laukaitis

Christina M. Laukaitis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christina M. Laukaitis has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring cross-category relationships between symptoms in people with hypermobile EDS (hEDS) to identify disability patterns

    by Jennifer Andrews, Zachery Harkey, Sarah Mathena, Maureen Galindo, Sarrah Hannon, Rohith Jesudas, Christina M. Laukaitis

    Background: Hypermobile Ehlers-Danlos Syndrome (hEDS) is a connective tissue disorder with variable symptom presentation across multiple organ systems and significant morbidity. Little is known about hEDS etiology and identifying patterns of symptom co-occurrence can reveal previously unidentified relationships between phenotypes and inform studies of underlying disease pathophysiology for symptoms that may share functional biological pathways. In this exploratory analysis, we specifically assessed the distribution of symptoms in case and controls to identify clusters of co-occurring symptoms. Methods: We have interrogated clinically relevant symptom areas in 47 females with hEDS, 36 age-matched female controls and 8 hypermobile patients without chronic pain. Studied symptoms include general health, mental health, body pain, vitality and energy, autonomic symptoms, bleeding, and gastrointestinal symptoms. We conducted hierarchal clustering on principle components (HCPC) to identify groups and compared the groups for the previously described symptoms. Radial plots were used to identify relationships between severe symptom categories. Results: Our analysis reveals statistically significantly more severe symptoms in all categories in people with hEDS compared with age- and sex-matched controls and asymptomatic hypermobile patients. HCPC identified clearly separated Low, Moderate, and High symptom groups within participants. The Low dysfunction groups include nearly all controls and hypermobile patients without chronic pain. The High dysfunction group includes ~60% of people with hEDS, while around 40% are in the Moderate dysfunction cluster. Cluster solutions for all participants were stable with moderate fit (silhouette 0.64; Jaccard boot mean 0.91). Group level radial plots showed high bleeding severity across all symptom clusters, while disproportional severity of general health, physical function, limitation of role due to physical symptoms, pain, and social functioning deficits differentiates the High from Moderate and Low Dysfunction clusters. Conclusion: Using this analysis at the group level has revealed patterns suggesting a progression of disease symptoms. People with hypermobility do not uniformly have severe symptoms but instead have some symptoms that differentiate from non-hypermobile individuals. While exploratory, using a radar multi-symptom analysis may be used to evaluate disproportionately severe symptoms contributing to the patterns of global symptom severity. These include pain but also ability to perform roles, suggesting strong utility of physical and occupational therapies to emphasize coping. This may also allow better targeting of etiological studies and may have additional utility at an individual level to develop symptom management strategies.

  • Open Access

    Obstructive sleep apnea and CPAP efficacy in patients with Hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: a case-control study

    by Kenneth L. Zhang, Rebecca Wallon, Christina M. Laukaitis, Charles Davies

    Purpose: Hypermobile Ehlers-Danlos syndrome (hEDS) and Hypermobility Spectrum Disorder (HSD) are hereditary tissue disorders existing on a spectrum associated with insomnia and obstructive sleep apnea (OSA). Oropharyngeal abnormalities in hEDS/HSD may exacerbate OSA; this study investigates if continuous positive airway pressure (CPAP) adequately decreases daytime sleepiness in hEDS/HSD patients with OSA. Methods: A single institution retrospective review was conducted from 2020 to 2024. Adults with hEDS/HSD and OSA (cases) were matched based on sex, age, race, and body mass index (BMI) to adults with OSA (controls). Data from polysomnogram (PSG), sleep clinic consults, and reevaluation 3–9 months post-CPAP were analyzed. The Epworth Sleepiness Scale (ESS) was used to assess daytime sleepiness. Results: 68 cases (47% hEDS/53% HSD, Beighton score 5.71 ± 2.29, age 34.07 ± 13.28, BMI 32.88 ± 8.47) were matched to 68 controls. All pairs completed PSG; 53 pairs pursued CPAP; 41 pairs were reevaluated. Cases had lower sleep efficiency (77%±16% vs. 82%±10%, p < 0.05) and higher insomnia prevalence (44.7% vs. 34.3%, p < 0.05). Pre-CPAP ESS was similar (10.39 ± 4.89 vs. 11.22 ± 5.12, p > 0.05). CPAP reduced ESS in controls (− 4.46, p < 0.05) but not in cases (− 1.56, p > 0.05). Cases and controls had similar CPAP compliance (75.6%±25.2% vs. 74.6%±26.7%, p > 0.05), Apnea-Hypopnea Index (AHI) (7.2 [13.6] vs. 7.0 [12.7], p > 0.05), lowest SpO 2 (86.08% ± 4.31% vs. 85.67% ± 3.52%, p > 0.05), and residual AHI (1.55 [1.75] vs. 1.2 [1.35], p > 0.05). Cases used nasal masks less frequently (22.6% vs. 41.5%, p < 0.05). Conclusion: CPAP was not associated with a statistically significant improvement in daytime sleepiness in hEDS/HSD patients despite effective treatment, suggesting that hypermobility-related factors beyond OSA may contribute to residual sleepiness.

  • Distressing Bleeding Symptoms in Interviews of Patients With Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorder

    by Rohith Jesudas, Sarah A. Mathena, Kenneth L. Zhang, Jennifer G. Andrews, Christina Laukaitis

    Introduction: Hypermobile Ehlers–Danlos Syndrome (hEDS) and hypermobility spectrum disorder (HSD) are associated with symptoms in many organ, but those related to haemostasis are not fully characterized. Aims: To determine the frequency of clinically significant excessive bleeding in this population as measured by the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH‐BAT) and its associated health‐related quality of life (HRQoL) concerns. Methods: Thirty‐five participants were enrolled from the hEDS GENE study. We use a mixed methodology approach to explore bleeding and other symptoms and their effect on participants life and health. This included self‐administered quantitative questionnaires and semi‐structured interviews, including the ISTH‐BAT. We assessed severity of distress related to bleeding using a novel quantitative assessment score based on our participant interview responses. Results: Nearly one third of participants reported clinically significant bleeding (ISTH‐BAT mean = 4.97) yet less than 10% of those received evaluation by haematology for bleeding. Heavy menstrual bleeding (HMB) was the most common bleeding symptom. Poor HRQoL related to multiple bleeding domains was reported. More than one third of participants reported significant distress from bleeding symptoms with a mean ISTH‐BAT score of 8.25. Conclusion: Bleeding is a significant clinical concern and cause of distress in people with hypermobility correlating with the severity of bleeding, reflected by a high bleeding score. This unique assessment tool needs validation in a larger patient cohort. Increased awareness and further evaluation of this condition is needed to adequately serve this patient population.


  • Geometry-Driven Mechanical Memory in a Random Fibrous Matrix

    by Mainak Sarkar, Christina Laukaitis, Amy Wagoner Johnson

    Disordered fibrous matrices, formed by the random assembly of fibers, provide the structural framework for many biological systems and biomaterials. Applied deformation modifies the alignment and stress states of constituent fibers, tuning the nonlinear elastic response of these materials. While it is generally presumed that fibers return to their original configurations after deformation is released, except when neighboring fibers coalesce or individual fibers yield, this reversal process remains largely unexplored. The intricate geometry of these matrices leaves an incomplete understanding of whether releasing deformation fully restores the matrix or introduces new microstructural deformation mechanisms. To address this gap, we investigated the evolution of matrix microstructures during the release of an applied deformation. Numerical simulations were performed on quasi-two-dimensional matrices of random fibers under localized tension, with fibers modeled as beams in finite element analysis. After tension release, the matrix exhibited permanent mechanical remodeling, with greater remodeling occurring at higher magnitudes of applied tension, indicative of the matrix preserving its loading history as mechanical memory. This response was surprising; it occurred despite the absence of explicit plasticity mechanisms, such as activation of interfiber cohesion or fiber yielding. We attributed the observed remodeling to the gradient in fiber alignment that developed within the matrix microstructure under applied tension, driving the subsequent changes in matrix properties during the release of applied tension. Therefore, random fibrous matrices tend to retain mechanical memory due to their intricate geometry.


  • Open Access

    A Broad Genome Survey Reveals Widespread Presence of Secretoglobin Genes in Squamate and Archosaur Reptiles that Flowered into Diversity in Mammals

    by Robert C Karn, Christina M Laukaitis

    Secretoglobins (SCGBs) are a superfamily of small, dimeric, cytokine-like proteins found originally in the reproductive tracts and airways of mammals. Most SCGB research has focused on respiratory diseases in humans and laboratory animal models but knowledge of their biological functions is sparse. We report here a broad survey of Scgbs, the genes that encode SCGBs, in animal genomes. We tested the view that they are uniquely mammalian in origin and distribution, hoping that understanding their distribution would shed light on their evolutionary history and perhaps point to putative biological functions. Rather than being uniquely mammalian, we found many different SCGBs in turtles, crocodilians, lizards, and birds, suggesting they existed in the Carboniferous Period (∼320 MYA) when the sauropsids evolved in the amniote lineage. We identified no SCGBs in amphibians or fishes, suggesting that this characteristic originated in an amniote ancestor. Amniotes include sauropsid and synapsid lineages, and three subfamilies of SCGBs (SCGB2A, SCGB3A, and SCGB1C) are found in both sauropsid and synapsid lineages. Uteroglobin (SCGB1A), the first identified SCGB protein, is uniquely mammalian, having appeared in monotremes. The SCGB subfamilies including androgen-binding proteins (SCGB1B and SCGB2B) are first seen in metatherians. This complex distribution suggests that there is an as-yet-undiscovered basic function of SCGBs shared by all amniotes.

  • Open Access

    Significant phenotypic variability in a multigenerational family with an NFIA missense mutation: Case series and review of the literature

    by Peyton Paschell, Christina Laukaitis

    Key Clinical Message: We report the first multigenerational family with NFIA‐related disorder from a missense variant. This case highlights the condition's phenotypic variability and the need for genetic testing when an initial diagnosis fails to explain all symptoms.


  • Open Access

    Physician practices in evaluation and treatment of patients with generalized joint hypermobility and bleeding

    by Nicole E. Kendel, Sarah H. O’brien, Christina M. Laukaitis, Manjusha Kumar, Howard P. Levy, Rohith Jesudas

    The association between bleeding and joint hypermobility may not be as diagnostically obvious in patients with milder connective tissue disorders. We surveyed members of the Hemostasis and Thrombosis Research Society regarding their knowledge, evaluation, and management practices in patients with generalized hypermobility spectrum disorder/hypermobile Ehlers–Danlos syndrome (hEDS) and bleeding symptoms. The objectives of this study were to (1) evaluate hematologists’ diagnosis and management practices for patients with bleeding symptoms and generalized hypermobility spectrum disorder/hEDS and (2) determine future education and research priorities regarding bleeding symptoms within this population. Evaluate hematologists’ diagnosis and management practices for patients with bleeding symptoms and generalized hypermobility spectrum disorder/hEDS. Determine future education and research priorities regarding bleeding symptoms within this population. A web-based survey was sent to Hemostasis and Thrombosis Research Society physician members. Physician demographics, preferred evaluation for hEDS, management of bleeding episodes, and referral patterns were collected and descriptive statistics were performed. Only two-thirds of respondents reported evaluating for hypermobility, despite all respondents being aware of the association with bleeding. There were significant variations in referral patterns for genetic counseling, diagnostic evaluation, and management of nonhematologic symptoms. There were also significant variations in reported medical homes for this patient population. Research prioritization included understanding the evolution of bleeding symptoms with age in this population as well as the development of functional tests to identify the molecular mechanism of bleeding and the development of novel hemostatic agents for this population. Results from 33 respondents show differing physician practices regarding the evaluation and management of bleeding in hypermobile patients. Many physicians suggested further research priorities to include studying the natural history of the disease and development of functional diagnostic testing as well as targeted therapeutic options in this patient population.


  • Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders

    by Kiana L. Martinez, Corina Mauss, Jennifer Andrews, Kathylynn Saboda, Julie M. Huynh, Alejandro J. Sanoja, Rohith Jesudas, Peter H. Byers, Christina M. Laukaitis

    The hypermobile Ehlers–Danlos syndrome (hEDS) GENE study is a multicenter, cohort study with the goal to identify genes associated with hypermobile EDS. Of the 148 people enrolled in the hEDS GENE study, 98 meet the 2017 hEDS criteria, 27 have a hypermobility spectrum disorder (HSD) and 23 are asymptomatic family members. More than 80% of participants are female with an average age of 41 years. Each participant has completed seven questionnaires to quantify disease‐related symptomatology. People with hypermobility experience a variety of physical and somatic symptoms, especially in the areas of fatigue, kinesiophobia, gastrointestinal, and autonomic function. These cause a significant decrease in health‐related quality of life. The frequency and severity of most symptoms were indistinguishable between participants with hEDS and HSD; however, there were significant differences in autonomic symptoms. Less than 20% of participants had autoantibodies known to be associated with dysautonomia. Subtle symptomatic differences in people meeting the 2017 diagnostic criteria suggest focusing further etiologic studies on autonomic pathways.


  • Human rDNA copy number is unstable in metastatic breast cancers

    by Virginia Valori, Katalin Tus, Christina Laukaitis, David T. Harris, Lauren LeBeau, Keith A. Maggert

    Chromatin-mediated silencing, including the formation of heterochromatin, silent chromosome territories, and repressed gene promoters, acts to stabilize patterns of gene regulation and the physical structure of the genome. Reduction of chromatin-mediated silencing can result in genome rearrangements, particularly at intrinsically unstable regions of the genome such as transposons, satellite repeats, and repetitive gene clusters including the rRNA gene clusters (rDNA). It is thus expected that mutational or environmental conditions that compromise heterochromatin function might cause genome instability, and diseases associated with decreased epigenetic stability might exhibit genome changes as part of their aetiology. We find the support of this hypothesis in invasive ductal breast carcinoma, in which reduced epigenetic silencing has been previously described, by using a facile method to quantify rDNA copy number in biopsied breast tumours and pair-matched healthy tissue. We found that rDNA and satellite DNA sequences had significant copy number variation – both losses and gains of copies – compared to healthy tissue, arguing that these genome rearrangements are common in developing breast cancer. Thus, any proposed aetiology onset or progression of breast cancer should consider alterations to the epigenome, but must also accommodate concomitant changes to genome sequence at heterochromatic loci.